NCT02016833View on ClinicalTrials.gov

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions
Ovarian Serous AdenocarcinomaUndifferentiated Carcinoma of OvaryCervical CancerCervical Intraepithelial Neoplasia, Grade 3Acute Myeloid LeukemiaChronic Myeloid Leukemia
Interventions
PROCEDURE

Blood Sampling

Sampling of 80mL of whole blood

Trial Locations (1)

3002

Peter MacCallum Cancer Center, Melbourne

Sponsors

Lead Sponsor

PX Biosolutions
All Listed Sponsors
lead

PX Biosolutions

INDUSTRY